Allison D C, Piantadosi S, Hruban R H, Dooley W C, Fishman E K, Yeo C J, Lillemoe K D, Pitt H A, Lin P, Cameron J L
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
J Surg Oncol. 1998 Mar;67(3):151-9. doi: 10.1002/(sici)1096-9098(199803)67:3<151::aid-jso2>3.0.co;2-8.
The 5-year survival rates after resection of pancreatic carcinoma have recently increased and are predicted by tumor size, DNA content, and lymph node metastases at the time of resection. However, whether the 10-year survival rates have also increased and are similarly predicted by these factors is not known.
The influence of preoperative imaging tests, alcohol consumption, cigarette smoking, K-ras mutations, anatomic location, details of surgical resection, pathologic findings, and tumor DNA content on survival was tested for 96 patients after a successful resection of a pancreatic carcinoma with 17 patients being followed for more than 5 years.
The 5- and 10-year patient survival rates were 18% and 3%, respectively. Univariate and multivariable analyses showed that tumor DNA content, pathologic tumor size, and lymph node metastases were the strongest prognostic indicators for long-term patient survival, although the importance of tumor size may diminish 2 or more years after resection. Surprisingly, the 11 patients with diploid carcinomas > or = 4 cm had an estimated 10-year survival rate of 36%.
These results show that the 10-year survival rate for pancreatic carcinoma remains very low, although the subset of patients with biologically favorable tumors has a prolonged survival and possible cure after resection.
胰腺癌切除术后的5年生存率近来有所提高,且可通过肿瘤大小、DNA含量及切除时的淋巴结转移情况进行预测。然而,10年生存率是否也有所提高以及是否同样可由这些因素预测尚不清楚。
对96例成功切除胰腺癌的患者进行研究,检测术前影像学检查、饮酒、吸烟、K-ras突变、解剖位置、手术切除细节、病理结果及肿瘤DNA含量对生存的影响,其中17例患者随访时间超过5年。
患者的5年和10年生存率分别为18%和3%。单因素和多因素分析表明,肿瘤DNA含量、病理肿瘤大小及淋巴结转移是患者长期生存的最强预后指标,尽管肿瘤大小的重要性在切除后2年或更长时间可能会降低。令人惊讶的是,11例肿瘤直径≥4cm的二倍体癌患者的估计10年生存率为36%。
这些结果表明,胰腺癌的10年生存率仍然很低,尽管生物学特性良好的肿瘤患者亚组在切除后生存期延长且有可能治愈。